Madrigal Pharmaceuticals(DE:YDO1)
€383.10-4.70 (-1.21%)
DE:YDO1
Madrigal Pharmaceuticals earnings date
€383.10
At close:-4.70 (-1.21%)
Madrigal Pharmaceuticals (YDO1) Q2 2024 Earnings Report
1 Followers
DE:YDO1 Q2 2024 EPS Results
- Actual EPS
- -EUR 6.40
- Consensus EPS
- -EUR 6.79
- Beat/Miss
- Beat by +EUR 0.39
- One Year Ago EPS
- -EUR 4.23
DE:YDO1 Q2 2024 Revenue Results
- Actual Revenue
- EUR 13.19M
- Expected Revenue
- EUR 3.83M
- Beat/Miss
- Beat by +EUR 9.36M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 7, 2024
DE:YDO1 Upcoming Earnings
Madrigal Pharmaceuticals's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:YDO1 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:YDO1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | 1.29- | -2.32 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.781.65 | -4.58 | 136.02% (+6.23) | |
| Jul 30, 2026 | 2026 (Q2) | -2.41-1.79 | -1.71 | -4.74% (-0.08) | |
| May 06, 2026 | 2026 (Q1) | -3.81-2.93 | -2.99 | 2.11% (+0.06) | |
| Feb 19, 2026 | 2025 (Q4) | -0.81-2.32 | -2.44 | 5.17% (+0.13) | |
| Nov 04, 2025 | 2025 (Q3) | -2.06-4.58 | -4.43 | -3.25% (-0.14) | |
| Aug 05, 2025 | 2025 (Q2) | -3.20-1.71 | -6.4 | 73.24% (+4.69) | |
| May 01, 2025 | 2025 (Q1) | -3.38-2.99 | -6.65 | 55.01% (+3.66) | |
| Feb 26, 2025 | 2024 (Q4) | -3.53-2.44 | -5.12 | 52.29% (+2.68) | |
| Oct 31, 2024 | 2024 (Q3) | -6.08-4.43 | -4.81 | 7.87% (+0.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

